Pediatric and Adolescent HAE eYardstick (Non-CME)

Price: Free for Members. $25 for Non-members.

This interactive eYardstick provides expert-informed, practical guidance on the diagnosis and management of hereditary angioedema (HAE) in pediatric and adolescent patients. Through concise, synthesized content, tables, and clinical decision-making tools, learners can explore updated disease classifications and diagnostic criteria, evidence-based approaches to individualized treatment, and the clinical considerations surrounding established and emerging therapies. Its intuitive, self-directed format allows clinicians to navigate the content according to their needs and use it as a point-of-practice resource when making treatment decisions for children and adolescents with HAE.

This activity is sponsored by an educational grant from Ionis Pharmaceuticals, Inc.

 

Target Audience

Allergists, allied health and other allergy practitioners

Learning Objectives

After participating in this activity, learners will be able to:

  • Describe the updated classifications of HAE in pediatrics and adolescent patients and apply current diagnostic criteria.
  • Apply evidence-based treatment strategies to individualize therapy for patients with HAE.
  • Evaluate the clinical indications, mechanisms of action, and efficacy data of emerging therapies for pediatric/adolescent HAE, including newly approved agents. 
  • Utilize expert-informed clinical frameworks or algorithms ("yardsticks") to guide therapeutic decision-making in the absence of formal guidelines.
Additional information
Disclosure: 

This activity is not certified for CME credit.

Disclaimer
The opinions expressed are those of the faculty and do not necessarily reflect the opinions of the ACAAI. The educational content was reviewed for content validity to ensure that it is evidence-based, balanced, scientifically objective, and free of commercial bias. This activity may include discussion of investigational, off-label, or unapproved uses of drugs and/or devices. Please refer to the FDA-approved prescribing information for each drug or device for complete information regarding approved uses and prescribing recommendations. 

Course summary

Course opens: 
09/17/2026
Course expires: 
09/16/2029
Cost:
$25.00
Rating: 
0

Timothy J. Craig, DO, FACAAI
Tenured Professor Medicine, Pediatrics, Biomedical Sciences at The Pennsylvania State University; Penn State University Distinguished Educator
Professor of Health Sciences Vin-University, Hanoi, Vietnam
Director- ACARE Center of Excellence for Angioedema; Director- Alpha-1-Antitrypsin Deficiency Center; Medical Advisory Board for the HAE-A; Director of AI and Respiratory Clinical Research; Senior Advisor, Vinmec Allergy Immunology, Hanoi, VN; Honorary Board of Directors, Lam Dong Medical College

Marc Riedl, MD, MS
Professor of Medicine
University of California, San Diego
San Diego, CA

Price

Cost:
$25.00
Please login or create an account to take this course.